Found 78 clinical trials
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients with Schizophrenia and Recent Weight Gain While Taking Antipsychotic Medications
To assess the efficacy of miricorilant compared with placebo in reversing recent antipsychoticinduced weight gain (AIWG)
- 47 views
- 23 Nov, 2020
- 1 location
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics.
This multicenter study will assess the effects of 24 weeks of basmisanil treatment on cognition and functioning of stable schizophrenia participants treated with antipsychotics.
- 33 views
- 22 Dec, 2020
- 1 location
Study to Assess the Antipsychotic Efficacy of a Study Drug for Patients with Schizophrenia
Study to Assess the Antipsychotic Efficacy of a Study Drug for Patients with Schizophrenia
- 220 views
- 23 Nov, 2020
- 1 location
Study to Evaluate an Investigational Drug in Patients With Schizophrenia on Stable Antipsychotic Treatment
Study to Evaluate an Investigational Drug in Patients With Schizophrenia on Stable Antipsychotic Treatment
- 244 views
- 23 Nov, 2020
- 1 location
Pharmacogenetic Supported Prescribing in Kids
Implementation of pharmacogenetic testing for children and adolescents aged 7-17 who are starting or changing psychiatric medication.
- 2 views
- 23 Mar, 2021
- 1 location
a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics
This study is a pilot phased interventional clinical trial . The first stage will recruit 10 patients with antipsychotic induced extrapyramidal symptoms.The patients will take pramipexole for 8 weeks. The inital dose of pramipexole will be 0.375 mg/d, and the adjustment of drug dose will be depended on the the …
- 0 views
- 23 Jan, 2021
- 1 location
Tolerability Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia
syndrome), currently treated with atypical antipsychotics. Patient Population: The intention is to treat 45 patients diagnosed with schizophrenia, who are currently suffering mainly from
- 0 views
- 07 Nov, 2020
- 1 location
The Effect of Guanfacine on Delirium in Critically Ill Patients
cost, increased ventilator days, and long-term cognitive disability. Various pharmacologic agents including dopamine antagonists, acetylcholinesterase inhibitors, melatonin, antipsychotics, alpha-2
- 2 views
- 26 Jan, 2021
- 1 location
Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes
which the patients present psychotic symptoms (positive symptoms, negative symptoms) and cognition deficits. Antipsychotics are often prescribed to treat these symptoms, but more than one third patients
- 0 views
- 02 May, 2021
- 3 locations
Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia
The aim of the present study was to investigate the efficacy of aripiprazole in management of pre-existing neuroleptic-induced tardive dyskinesia
- 53 views
- 07 Nov, 2020
- 1 location